These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24830889)

  • 1. Challenges in selectivity, specificity and quantitation range of ligand-binding assays: case studies using a microfluidics platform.
    Yang TY; Uhlinger DJ; Ayers SA; O'Hara DM; Joyce AP
    Bioanalysis; 2014 Apr; 6(8):1049-57. PubMed ID: 24830889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing matrix effects in ligand-binding assays through the use of new reagents and technology.
    Chilewski SD; Mora JR; Gleason C; DeSilva B
    Bioanalysis; 2014 Apr; 6(8):1059-67. PubMed ID: 24830890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-binding assays: risk of using a platform supported by a single vendor.
    Yohrling J
    Bioanalysis; 2009 Jun; 1(3):629-36. PubMed ID: 21083158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating Regulated Bioanalysis for Biotherapeutics: Case Examples Using a Microfluidic Ligand Binding Assay Platform.
    Liu R; Hoffpauir B; Chilewski SD; Gamberdella J; Kavita U; Duo J; Gleason C; Zhang Y; Pillutla R; DeSilva B; Hamuro L
    AAPS J; 2017 Jan; 19(1):82-91. PubMed ID: 27796911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miniaturized immunoassay microfluidic system with electrokinetic control.
    Xiang Q; Hu G; Gao Y; Li D
    Biosens Bioelectron; 2006 Apr; 21(10):2006-9. PubMed ID: 16289606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of four distinct detection platforms using multiple ligand binding assay formats.
    Soderstrom CI; Spriggs FP; Song W; Burrell S
    J Immunol Methods; 2011 Aug; 371(1-2):106-13. PubMed ID: 21749873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid, sensitive and real-time multiplexing platform for the analysis of protein and nucleic-acid biomarkers.
    Falconnet D; She J; Tornay R; Leimgruber E; Bernasconi D; Lagopoulos L; Renaud P; Demierre N; van den Bogaard P
    Anal Chem; 2015 Feb; 87(3):1582-9. PubMed ID: 25567587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of miniaturized immunoassays to discovery pharmacokinetic bioanalysis.
    Roman J; Qiu J; Dornadula G; Hamuro L; Bakhtiar R; Verch T
    J Pharmacol Toxicol Methods; 2011; 63(3):227-35. PubMed ID: 21147239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoassay using microfluid filters constructed by deep X-ray lithography.
    Matsui K; Kawaji I; Utsumi Y; Ukita Y; Asano T; Takeo M; Kato D; Negoro S
    Biosci Biotechnol Biochem; 2007 Dec; 71(12):3098-101. PubMed ID: 18071245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical assay platforms for soluble target engagement biomarkers: old favorites and emerging technologies.
    Goodman J; Agoram B
    Bioanalysis; 2013 Dec; 5(23):2919-31. PubMed ID: 24295118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast multiplex analysis of antibodies in complex sample matrix using the microfluidic Evalution™ platform.
    Leirs K; Leblebici P; Lammertyn J; Spasic D
    Anal Chim Acta; 2017 Aug; 982():193-199. PubMed ID: 28734359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical ligand binding reagent preparation/selection: when specificity depends on reagents.
    Rup B; O'Hara D
    AAPS J; 2007 May; 9(2):E148-55. PubMed ID: 17614357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Due diligence in the characterization of matrix effects in a total IL-13 Singulex™ method.
    Fraser S; Soderstrom C
    Bioanalysis; 2014 Apr; 6(8):1123-9. PubMed ID: 24830896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic force-based multiplexed immunoassay using superparamagnetic nanoparticles in microfluidic channel.
    Kim KS; Park JK
    Lab Chip; 2005 Jun; 5(6):657-64. PubMed ID: 15915258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Singlicate Ligand Binding Assay Using an Automated Microfluidic System: a Clinical Case Study.
    Jiang H; Kozhich A; Cummings J; Gambardella J; Zambito F; Titsch C; Haulenbeek J; Phillips K; Fergus R; Myler H
    AAPS J; 2017 Sep; 19(5):1461-1468. PubMed ID: 28589510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of laminar flow patterning for miniaturised biochemical assays.
    Regenberg B; Krühne U; Beyer M; Pedersen LH; Simon M; Thomas OR; Nielsen J; Ahl T
    Lab Chip; 2004 Dec; 4(6):654-7. PubMed ID: 15570380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation into the applicability of the centrifugal microfluidics platform for the development of protein-ligand binding assays incorporating enhanced green fluorescent protein as a fluorescent reporter.
    Puckett LG; Dikici E; Lai S; Madou M; Bachas LG; Daunert S
    Anal Chem; 2004 Dec; 76(24):7263-8. PubMed ID: 15595868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A digital microfluidic approach to homogeneous enzyme assays.
    Miller EM; Wheeler AR
    Anal Chem; 2008 Mar; 80(5):1614-9. PubMed ID: 18220413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of matrix interference: quantitative and quasi-quantitative ligand-binding assays case studies.
    Spriggs FP; Duriga N; Rathi A; Qu Q
    Bioanalysis; 2014 Apr; 6(8):1093-101. PubMed ID: 24830893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microfluidic platform for high-throughput multiplexed protein quantitation.
    Volpetti F; Garcia-Cordero J; Maerkl SJ
    PLoS One; 2015; 10(2):e0117744. PubMed ID: 25680117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.